- USTR's 2015 Special 301 List
- 30 April 2015, KEI Seminar on Drug Pricing: Paul Grootendorst on Canadian Drug Pricing
- California AB 463 (Pharmacetical Cost Transparency Act of 2015) Held Over as Two-Year Bill
- Kassy Perry, speaking on behalf of ?, opposing AB 463, on transparency of drug R&D costs and subsidies
- Public Citizen, National Physicians Alliance, Other Civil Society Groups Write Letters in Support of California AB 463
- KEI Notes on California Assembly Health Committee Markup on AB 463 Pharmaceutical Cost Transparency Act of 2015
- KEI Seminars on Drug Pricing: 30 April 2015, Prof. Paul Grootendorst on the Canadian approach to drug pricing
- OCR version of leaked EU document on : "A digital single market strategy for Europe"
- WIPO CDIP 15: Statement of Brazil on evaluation of the Project on Open Collaborative Projects and IP-Based Models
- The CA State Assembly Health Committee staff analysis of AB463; includes who supports and opposes
On Wednesday, 19 May 2010, the launch of the 2.3(c) Committee will take place at Room XXV of the Palais de Nations from 13:00 to 14:30. Element 2.3(c) of the WHO Global Strategy on Public Health, Innovation and Intellectual Property states:
encourage further exploratory discussions on the utility of possible instruments or mechanisms for essential health and biomedical R&D, including inter alia, an essential health and biomedical R&D treaty
WHO donors (US, Gates Foundation, UK, Norway, Canada, EC, GAVI and Roche): Setting the agenda for global public health?Submitted by thiru on 15. May 2010 - 5:25
As the 63rd World Health Assembly (WHA) opens on May 17, 2010, WHO member countries will meet to consider matters of great moment including such topics as 'counterfeit medical products', pandemic influenza preparedness (sharing of influenza viruses and access to vaccines and other benefits) and the Report of the WHO Expert Working Group on R&D Financing.
In a letter dated 4 May 2010, the Director General of the World Trade Organization (WTO), Pascal Lamy has responded to questions and concerns of the European Parliament regarding the Anti Counterfeiting Trade Agreement (ACTA).
12 May 2010
Statement of Knowledge Ecology International on possible WTO disputes against the EU seizures of goods in transit
Thiru Balasubramaniam, Geneva Representative
“In a world with territorial patent rights, it is important that the rules for ‘goods in transit’ permit the transport of medicines from places where they can be made to places where they will be used. The EU's systematic seizure of at least 17 drug consignments is indefensible and undermines the very principle of free trade, the raison d’être of the World Trade Organization.
USTR has released its 2010 Special 301 list. Closely following the IIPI and the PhRMA asks, the Special 301 Priority Watch List countries are: Algeria, Argentina, Canada, Chile, China, India, Indonesia, Pakistan, Russia, Thailand, and Venezuela. Among high income countries, Finland, Norway and Spain made the Watch list this year. Sweden was off.
On April 21, 2010, an official version of the consolidated negotiating text of the proposal Anti-Counterfeiting Trade Agreement (ACTA) was published. Next Wednesday, April 28, 2010, the Trans-Atlantic Consumer Dialogue (TACD) will host a series of roundtable discussions about the new ACTA text at the US Department of commerce, Washington, DC from 9am to 3pm.
Senator Wyden issues statement on release of ACTA negotiating text, warns "poorly constructed agreement" would harm consumersSubmitted by James Love on 22. April 2010 - 2:37
This is an important statement by Senator Ron Wyden, the Chair of the Senate Subcommittee on International Trade, Customs and Global Competitiveness. He mentions the importance of transparency in giving the public an opportunity to "understand and shape" the agreement, and he warns that a "poorly constructed agreement could be harmful to consumers’ ability to use the Internet and could stifle the type of innovation needed to create new American jobs."
Briefing on the Report of the WHO Expert Working Group on R&D Financing
19 April, 2010
Rue de Lausanne 78, Salle LEH
Médecins Sans Frontières
The WHA Executive Board (EB) has been asked to submit to the 2010 World Health Assembly (WHA) a report by the the WHO Expert Working Group on R&D Financing. This report was presented to the WHO EB in January 2010. A meeting of the EB to consider the report will be held on May 13, 2010.
The briefing on Monday April 19 will review the following topics.
9:30am – 10:00am
On April 28, TACD will be holding a meeting from 9 am to 3 pm at the U.S. Department of Commerce, in Washington, DC, to discuss the proposed Anti-Counterfeiting Trade Agreement (ACTA).
KEI has issued a new research note, Comments on ACTA Provisions on Injunctions and Damages, KEI Research Note 2010:1, dated April 6, 2010.
DOJ files amicus brief supporting controversial use of copyright claim to block parallel trade of Omega watchesSubmitted by James Love on 31. March 2010 - 13:17
In a parallel trade case involving Costco, a popular discount outlet, and Omega, the Swiss watchmaker, the US Department of Justice has come down against U.S. consumers, backing the Swiss companies use of copyright laws to block imports of watches sold at lower prices outside of the US, by Omega. A copy of the DOJ brief is available here. Costco filed a response, which is available here.
In today's court ruling in Association for Molecular Pathology, et al. v. USPTO, et al., Judge Robert Sweet rejected claims by Myriad that invaliding the patents would be an unconstitutional taking, or violate the WTO TRIPS Agreement. In discussing the TRIPS, Judge Sweet mentioned Article 8.1 and 27.3 of the TRIPS.
Ben King of the New Zealand Ministry of Foreign Affairs and Trade has kindly provided some details of the April 13, 2010 meeting between ACTA negotiators and private sector stakeholders. The event is "by invitation only" but we are told it will include civil society groups. Inquiries about April 13 event can be forwarded to firstname.lastname@example.org
-------- Forwarded Message --------
From: KING, Ben (WSH)
To: Jamie Love
Subject: From New Zealand Embassy
Michael Geist has leaked the lasted draft of the intellectual property chapter of the Canada - EU Comprehensive Economic Trade Agreement. These are some brief comments on the new document.
It applies to both parties.
When a very large trading partner negotiates with a smaller one, it is sometimes overlooked that the norms are designed to bind both parties. So the Canada/EU IPR agreement should be of interest to Canada and the 27 members of the European Union.